SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001649094-24-000010
Filing Date
2024-06-10
Accepted
2024-06-10 16:07:03
Documents
3
Period of Report
2024-06-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1718050014.html 4  
1 FORM 4 wk-form4_1718050014.xml 4 6526
2 EX-24 poasection16filings-hirt.htm EX-24 4129
3 GRAPHIC poasection16filings-hirt001.jpg GRAPHIC 249637
  Complete submission text file 0001649094-24-000010.txt   356129
Mailing Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070 650-837-0111
Vaxcyte, Inc. (Issuer) CIK: 0001649094 (see all company filings)

IRS No.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O VAXCYTE, INC. 353 HATCH DRIVE FOSTER CITY CA 94404
Business Address
Hirth Peter (Reporting) CIK: 0001813780 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39323 | Film No.: 241032708